Differences in COPD management across clinician type: Maintenance treatment habits and patient characteristics among US pulmonologists, internal/family medicine physicians, nurse practitioners, and physician assistants
Unterschiede im COPD-Management nach Behandlertyp: Erhaltungstherapie-Gewohnheiten und Patientenmerkmale bei US-Pneumolog:innen, Ärzt:innen für Innere/Allgemeinmedizin, Nurse Practitioners und Physician Assistants
Chronic Respiratory Disease · 2025-04 · 22
DOI: 10.1177/14799731251346191 ↗Auf einen Blick
Eine retrospektive Querschnittserhebung zeigte Unterschiede im COPD-Behandlungsverhalten zwischen US-Kliniker:innen. Innere/Allgemeinmedizin und NP/PA verschrieben häufiger LABA/ICS, Pneumolog:innen bevorzugten duale Bronchodilatation.
Fragestellung
Unterscheiden sich Patientenmerkmale und Behandlungsmuster bei COPD je nach Behandlertyp in den USA?
Methode
Retrospektive Querschnittserhebung mit aus Krankenakten abstrahierten Daten von COPD-Patient:innen durch Pneumolog:innen, Ärzt:innen für Innere/Allgemeinmedizin, NPs und PAs.
Ergebnisse
Daten zu 700 Patient:innen von 175 Kliniker:innen: 100 Pneumolog:innen, 45 Inner-/Allgemeinmediziner:innen, 30 NP/PA. 11 % mild, 51 % moderat, 38 % schwer/sehr schwer. Duale Therapien wurden je nach Behandlertyp unterschiedlich verordnet.
Schlussfolgerung der Autor:innen
Die Autor:innen berichten Unterschiede in den COPD-Behandlungsmustern zwischen US-Kliniker:innen. Trotz Erhaltungstherapie hatte COPD einen deutlichen Einfluss auf die Patient:innen; bessere Therapien seien nötig.
Kernaussagen
- 700 Patient:innen aus 175 Kliniker:innen erfasst
- LABA/ICS häufiger bei Inner-/Allgemeinmedizin und NP/PA
- Pneumolog:innen bevorzugten duale Bronchodilatation
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Chronic Respiratory Disease, online erschienen am 05.06.2025. Verfasst von Mario Castro und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Kansas Medical Center, Kansas City, KS, USA. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Muscarinic Antagonists, Practice Patterns, Physicians', Bronchodilator Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Verona Pharma.
Themen: COPD
Abstract (Originalsprache)
Objectives
Treatment recommendations for chronic obstructive pulmonary disease (COPD) are based on single or combination long-acting bronchodilator therapy (β 2 -agonists [LABAs] or muscarinic receptor antagonists [LAMAs]), with inhaled corticosteroids (ICS) for those at risk of exacerbations. This study evaluated differences in patient characteristics and treatment patterns among US clinicians.
Methods
Medical record data for patients with COPD were abstracted via a retrospective cross-sectional survey by pulmonologists, internal/family medicine physicians, nurse practitioners (NPs) and physician assistants (PAs).
Results
Data on 700 patients were collected from 175 clinicians: 100 pulmonologists, 45 internal/family medicine physicians, 30 NP/PAs. Respondents classified patients as having Mild (11%), Moderate (51%), or Severe/Very Severe (38%) COPD, with highest perceived disease burden for patients with Severe/Very Severe COPD. Dual therapies were prescribed differently according to clinician type. Internal/family medicine physicians and NP/PAs prescribed LABA/ICS to a significantly higher proportion of patients than pulmonologists, who favored use of dual bronchodilator therapy. Regardless of clinician type, COPD management was complex, with patients starting and transitioning to multiple treatments throughout their care.
Conclusion
Differences in COPD treatment patterns exist across US clinicians. Despite current maintenance treatment, COPD had a profound impact on patients, indicating a need for improved therapies for COPD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, University of Kansas Medical Center, Kansas City, KS, USA.
- Department of Thoracic Medicine & Surgery, Temple University Hospital, Philadelphia, PA, USA.
- Trinity Life Sciences, Waltham, MA, USA.
- Medical Affairs, Verona Pharma, Raleigh, NC, USA.
- Department of Family and Community Health, University of Minnesota, Minneapolis, MN, USA.
Förderung
- Verona Pharma
Zitieren
APA
Castro, M., Carney, K. C., Romanelli, S. M., Dixon, A. L., Abdul Rahman, M. Q., Aggarwal, K., & Yawn, B. P. (2025). Differences in COPD management across clinician type: Maintenance treatment habits and patient characteristics among US pulmonologists, internal/family medicine physicians, nurse practitioners, and physician assistants. Chronic Respiratory Disease, 22. https://doi.org/10.1177/14799731251346191
Vancouver
Castro M, Carney KC, Romanelli SM, Dixon AL, Abdul Rahman MQ, Aggarwal K, et al. Differences in COPD management across clinician type: Maintenance treatment habits and patient characteristics among US pulmonologists, internal/family medicine physicians, nurse practitioners, and physician assistants. Chronic Respiratory Disease. 2025;22. doi:10.1177/14799731251346191
BibTeX
@article{Castro2025,
author = {Castro, Mario and Carney, Kevin C and Romanelli, Steven M and Dixon, Amy L and Abdul Rahman, Maryam Q and Aggarwal, Kavita and Yawn, Barbara P},
title = {Differences in COPD management across clinician type: Maintenance treatment habits and patient characteristics among US pulmonologists, internal/family medicine physicians, nurse practitioners, and physician assistants},
journal = {Chronic Respiratory Disease},
year = {2025},
volume = {22},
doi = {10.1177/14799731251346191}
}
EUVIMED